Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 14, 2020
Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytesChristopher Keefer, George Chang, Anthony Carlo, et al.Organic Letters|June 6, 2015
Peptide to Peptoid Substitutions Increase Cell Permeability in Cyclic HexapeptidesJoshua Schwochert, Rushia Turner, Melissa Thang, et al.NEJM Evidence|February 6, 2024
Outpatient Randomized Controlled Trials in the Covid-19 Era and BeyondJean M Connors, Maria M Brooks, Frank C Sciurba, et al.JAMA|October 11, 2021
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical TrialJean M Connors, Maria M Brooks, Frank C Sciurba, et al.Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.Bioorganic & Medicinal Chemistry Letters|November 17, 2012
Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitorsSamit K Bhattacharya, Gary E Aspnes, Scott W Bagley, et al.Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.Journal of American College Health : J of ACH|January 3, 2023
SARS-CoV-2 control on a large urban college campus without mass testingChristopher O'Donnell, Katherine Brownlee, Elise Martin, et al.Journal of Medicinal Chemistry|October 29, 2015
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular DiseasesRoger B Ruggeri, Leonard Buckbinder, Scott W Bagley, et al.Journal of Medicinal Chemistry|August 5, 2016
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic NephropathyKimberly O Cameron, Daniel W Kung, Amit S Kalgutkar, et al.Pageof 8